Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Occupational Medicine and Toxicology
Published in: Journal of Occupational Medicine and Toxicology 1/2011

Open Access 01-12-2011 | Review

Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission

Author: Joachim Mutter

Published in: Journal of Occupational Medicine and Toxicology | Issue 1/2011

Login to get access

Abstract

It was claimed by the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)) in a report to the EU-Commission that "....no risks of adverse systemic effects exist and the current use of dental amalgam does not pose a risk of systemic disease..." [1, available from: http://​ec.​europa.​eu/​health/​ph_​risk/​committees/​04_​scenihr/​docs/​scenihr_​o_​016.​pdf].
SCENIHR disregarded the toxicology of mercury and did not include most important scientific studies in their review. But the real scientific data show that:
(a) Dental amalgam is by far the main source of human total mercury body burden. This is proven by autopsy studies which found 2-12 times more mercury in body tissues of individuals with dental amalgam. Autopsy studies are the most valuable and most important studies for examining the amalgam-caused mercury body burden.
(b) These autopsy studies have shown consistently that many individuals with amalgam have toxic levels of mercury in their brains or kidneys.
(c) There is no correlation between mercury levels in blood or urine, and the levels in body tissues or the severity of clinical symptoms. SCENIHR only relied on levels in urine or blood.
(d) The half-life of mercury in the brain can last from several years to decades, thus mercury accumulates over time of amalgam exposure in body tissues to toxic levels. However, SCENIHR state that the half-life of mercury in the body is only "20-90 days".
(e) Mercury vapor is about ten times more toxic than lead on human neurons and with synergistic toxicity to other metals.
(f) Most studies cited by SCENIHR which conclude that amalgam fillings are safe have severe methodical flaws.
Literature
1.
2.
Barregard J, Svalander C, Schutz A, Westberg G, Sällsten G, Blohmé I, Mölne J, Attman PO, Haglind P: Cadmium, mercury, and lead in kidney cortex of the general Swedish population: a study of biopsies from living kidney donors. Environ Health Perspect 1999, 107: 867–871.PubMedCentralPubMedCrossRef
3.
Becker K, Kaus S, Krause C, Lepom P, Schulz C, Seiwert M, Seifert B: German Environmental Survey 1998 (GerES lll): environmental pollutants in blood of the German population. Int J Hyg Environ Health 2002, 205: 297–308. 10.1078/1438-4639-00155PubMedCrossRef
4.
Becker K, Schulz C, Kaus S, Seiwert M, Seifert B: German Environmental Survey 1998 (GerES III): Environmental pollutants in the urine of the German population. Int J Hyg Environ Health 2003, 206: 15–24. 10.1078/1438-4639-00188PubMedCrossRef
5.
Drasch G, Schupp I, Riedl G, Günther G: Einfluß von Amalgamfüllungen auf die Quecksilberkonzentration in menschlichen Organen. Dtsch Zahnärztl Z 1992, 47: 490–496.
6.
Drasch G, Schupp I, Hofl H, Reinke R, Roider G: Mercury burden of human fetal and infant tissues. Eur J Ped 1994, 153: 607–610. 10.1007/BF02190671CrossRef
7.
Drasch G, Wanghofer E, Roider G: Are blood, urine, hair, and muscle valid bio-monitoring parameters for the internal burden of men with the heavy metals mercury, lead and cadmium? Trace Elem Electrolyt 1997, 14: 116–123.
8.
Eggleston DW, Nylander M: Correlation of dental amalgam with mercury in brain tissue. J Prosth Dent 1987, 58: 704–707. 10.1016/0022-3913(87)90424-0CrossRef
9.
Gottwald B, Traencker I, Kupfer J, Ganss C, Eis D, Schill WB, Gieler U: "Amalgam disease" -- poisoning, allergy, or psychic disorder? Int J Hyg Environ Health 2001, 204: 223–229. 10.1078/1438-4639-00097PubMedCrossRef
10.
Guzzi G, Grandi M, Cattaneo C: Should amalgam fillings be removed? Lancet 2002, 360: 2081. 10.1016/S0140-6736(02)11971-4PubMedCrossRef
11.
Guzzi G, Grandi M, Cattaneo C, Calza S, Minoia C, Ronchi A, Gatti A, Severi G: Dental amalgam and mercury levels in autopsy tissues: food for thought. Am J Forensic Med Pathol 2006, 27: 42–45. 10.1097/01.paf.0000201177.62921.c8PubMedCrossRef
12.
Levy M, Schwartz S, Dijak M, Weber JP, Tardif R, Rouah F: Childhood urine mercury excretion: dental amalgam and fish consumption as exposure factors. Environ Res 2004, 94: 283–290. 10.1016/j.envres.2003.07.004PubMedCrossRef
13.
Lorscheider FL, Vimy MJ, Summers AO: Mercury exposure from "silver" tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB Journal 1995, 9: 504–508.PubMed
14.
Kingman A, Albertini T, Brown LJ: Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J Dent Res 1998, 77: 461–471. 10.1177/00220345980770030501PubMedCrossRef
15.
Mortada WI, Sobh MA, El-Defrawy MM, Farahat SE: Mercury in dental restoration: is there a risk of nephrotoxicity? J Nephrol 2002, 15: 171–176.PubMed
16.
Nylander M: Mercury in pituitary glands of dentists. Lancet 1986, 22: 442. 10.1016/S0140-6736(86)92395-0CrossRef
17.
Nylander M, Weiner J: Mercury and selenium concentrations and their interrelations in organs from dental staff and the general population. Br J Ind Med 1991, 48: 729–734.PubMedCentralPubMed
18.
Nylander M, Friberg L, Lind B: Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed Dent J 1987, 11: 179–187.PubMed
19.
Pizzichini M, Fonzi M, Giannerini M, Mencarelli M, Gasparoni A, Rocchi G, Kaitsas V, Fonzi L: Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors. Sci Total Environ 2003, 301: 43–50. 10.1016/S0048-9697(02)00291-7PubMedCrossRef
20.
Weiner JA, Nylander M: The relationship between mercury concentration in human organs and different predictor variables. Sci Tot Environ 1993, 138: 101–115. 10.1016/0048-9697(93)90408-XCrossRef
21.
Zimmer H, Ludwig H, Bader M: Determination of mercury in blood, urine and saliva for the biological monitoring of an exposure from amalgam fillings in a group with self-reported adverse health effects. Int J Hyg Environ Health 2002, 205: 205–211. 10.1078/1438-4639-00146PubMedCrossRef
22.
Danscher G, Hørsted-Bindsley P, Rungby J: Traces of mercury in organs from primates with amalgam fillings. Exp Mol Pathol 1990, 52: 291–299. 10.1016/0014-4800(90)90070-TPubMedCrossRef
23.
Galic N, Prpic-Mehicic G, Prester LJ, Blanusa M, Krnic Z, Ferencic Z: Dental amalgam mercury exposure in rats. Biometals 1999, 12: 227–237. 10.1023/A:1009267513632PubMedCrossRef
24.
Galic N, Prpic-Mehicic G, Prester LB, Krnic Z, Blanusa M, Erceg D: Elimination of mercury from amalgam in rats. J Trace Elem Med Biol 2001, 15: 1–4. 10.1016/S0946-672X(01)80018-3PubMedCrossRef
25.
Hahn LJ, Kloiber R, Vimy MJ, Takahashi Y, Lorscheider FL: Dental "silver" tooth fillings: a source of mercury exposure revealed by whole-body image scan and tissue analysis. FASEB Journal 1989, 3: 2641–2646.PubMed
26.
Hahn LJ, Kloiber R, Leininger RW, Vimy M, Lorscheider FL: Whole-body imaging of the distribution of mercury released from dental fillings into monkey tissues. FASEB Journal 1990, 4: 3256–3260.PubMed
27.
Lorscheider FL, Vimy MJ: Mercury exposure from "silver" fillings. Lancet 1991, 337: 1103. 10.1016/0140-6736(91)91757-LPubMedCrossRef
28.
Vimy MJ, Takahashi Y, Lorscheider FL: Maternal-fetal distribution of mercury (203 Hg) released from dental amalgam fillings. Am J Physiol 1990, 258: 939–945.
29.
Heintze U, Edwardsson S, Derand T, Birkhed D: Methylation of mercury from dental amalgam and mercuric chloride by oral streptococci in vitro. Scand J Dent Re 1983, 91: 150–152.
30.
Leistevuo J, Leistevuo T, Helenius H, Pyy L, Osterblad M, Huovinen P, Tenovuo J: Dental amalgam fillings and the amount of organic mercury in human saliva. Caries Res 2001, 35: 163–166. 10.1159/000047450PubMedCrossRef
31.
Yannai S, Berdicevsky I, Duek L: Transformations of inorganic mercury by Candida albicans and Saccharomyces cerevisiae. Appl Environ Microbiol 1991, 57: 245–247.PubMedCentralPubMed
32.
Leong CCW, Syed NI, Lorscheider FL: Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuro Report 2001, 12: 733–737.
33.
Olivieri G, Brack C, Muller-Spahn F, Stähelin HB, Herrmann M, Renard P, Brockhaus M, Hock C: Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J Neurochem 2000, 71: 231–236.
34.
Olivieri G, Novakovic M, Savaskan E, Meier F, Baysang G, Brockhaus M, Müller-Spahn F: The effects of ß-Estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and ß-Amyloid secretion. Neuroscience 2002, 113: 849–855. 10.1016/S0306-4522(02)00211-7PubMedCrossRef
35.
Pendergrass JC, Haley BE: Mercury-EDTA Complex Specifically Blocks Brain-Tubulin-GTP Interactions: Similarity to Observations in Alzheimer's Disease. In Status Quo and Perspective of Amalgam and Other Dental Materials. International Symposium Proceedings. Edited by: Friberg LT, Schrauzer GN. Stuttgart: Thieme Verlag; 1995:98–105.
36.
Pendergrass JC, Haley BE: Inhibition of brain tubulin-guanosine 5'-triphosphate interactions by mercury: similarity to observations in Alzheimer's diseased brain. In MetalIons on Biological systems. Edited by: Sigel A, Sigel H. New York: Dekker; 1997:461–478.
37.
Björkman L, Lundekvam BF, Laegreid T: Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ Health 2007, 11: 6:30.
38.
Wenstrup D, Ehmann WD, Markesbery WR: Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Research 1990, 533: 125–31. 10.1016/0006-8993(90)91804-PPubMedCrossRef
39.
Ehmann WD, Markesbery WR, Alauddin M, Hossain TIM, Brubakern EH: Brain trace elements in Alzheimer's disease. Neurotoxicology 1986, 7: 197–206.
40.
Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE: Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 1988, 9: 1–8.PubMed
41.
Saxe SR, Wekstein MW, Kryscio RJ, Henry RG, Cornett CR, Snowdon DA, Grant FT, Schmitt FA, Donegan SJ, Wekstein DR, Ehmann WD, Markesbery WR: Alzheimer's disease, dental amalgam and mercury. J Am Dent Ass 1999, 130: 191–199.PubMedCrossRef
42.
Cornett CR, Ehmann WD, Wekstein DR, Markesbery WR: Trace elements in Alzheimer's disease pituitary glands. Biol Trace Element Res 1998, 62: 107–114. 10.1007/BF02820026CrossRef
43.
Braak H: Neuroanatomy of Alzheimer's disease. Alzheimer's Disease Review 1997, 3: 235–47.
44.
Mutter J, Naumann J, Sadaghiani C, Schneider R, Walach H: Alzheimer Disease: Mercury as a pathogenic factor and apolipoprotein E as a moderator. Neuro Endocrinol Lett 2004, 25: 275–283.
45.
Ask K, Akesson A, Berglund M, Vahter M: Inorganic mercury and methylmercury in placentas of Swedish women. Environ Health Perspect 2002, 110: 523–526. 10.1289/ehp.02110523PubMedCentralPubMedCrossRef
46.
Holmes AS, Blaxill MF, Haley BE: Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 2003, 22: 277–85. 10.1080/10915810305120PubMedCrossRef
47.
Morgan DL, Chanda SM, Price HC, Fernando R, Liu J, Brambila E, O'Connor RW, Beliles RP, Barone S Jr: Disposition of inhaled mercury vapor in pregnant rats: maternal toxicity and effects on developmental outcome. Toxicol Sci 2002, 66: 261–273. 10.1093/toxsci/66.2.261PubMedCrossRef
48.
Takahashi Y, Tsuruta S, Hasegawa J, Kameyama Y, Yoshida M: Release of mercury from dental amalgam fillings in pregnant rats and distribution of mercury in maternal and fetal tissues. Toxicology 2001, 163: 115–126. 10.1016/S0300-483X(01)00390-0PubMedCrossRef
49.
Takahashi Y, Tsuruta S, Arimoto M, Tanaka H, Yoshida M: Placental transfer of mercury in pregnant rats which received dental amalgam restorations. Toxicology 2003, 185: 23–33. 10.1016/S0300-483X(02)00588-7PubMedCrossRef
50.
Vahter M, Akesson A, Lind B, Bjors U, Schutz A, Berglund F: Longitudinal study of methylmercury and inorganic mercury in blood and urin of pregnant and lactating women, as well as in umbilical cord blood. Environ Res 2000, 84: 186–194. 10.1006/enrs.2000.4098PubMedCrossRef
51.
Yoshida M, Satoh M, Shimada A, Yamamoto E, Yasutake A, Tohyama C: Maternal-to-fetus transfer of mercury in metallothionein-null pregnant mice after exposure to mercury vapor. Toxicology 2002, 175: 215–222. 10.1016/S0300-483X(02)00084-7PubMedCrossRef
52.
Yoshida M, Watanabe C, Satoh M, Yasutake A, Sawada M, Ohtsuka Y, Akama Y, Tohyama C: Susceptibility of Metallothionein-Null Mice to the Behavioural Alterations Caused by Exposure to Mercury Vapour at Human-Relevant Concentration. Toxicol Sci 2004, 80: 69–73. 10.1093/toxsci/kfh138PubMedCrossRef
53.
Luglie PF, Campus G, Chessa G, Spano G, Capobianco G, Fadda GM, Dessole S: Effect of amalgam fillings on the mercury concentration in human amniotic fluid. Arch Gynecol Obstet 2005, 271: 138–142. 10.1007/s00404-003-0578-6PubMedCrossRef
54.
Drasch G, Aigner S, Roider G, Staiger F, Lipowskyn G: Mercury in human colostrum and early breast milk. Its dependence on dental amalgam and other factors. J Trace Elem Med Biol 1998, 12: 23–27.PubMedCrossRef
55.
Oskarsson A, Schultz A, Skerfving S, Hallen IP, Ohlin B, Lagerkvist BJ: Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women. Arch Environ Health 1996, 51: 234–241. 10.1080/00039896.1996.9936021PubMedCrossRef
56.
Vimy MJ, Hooper DE, King WW, Lorscheider FL: Mercury from maternal "silver" tooth fillings in sheep and human breast milk. A source of neonatal exposure. Biol Trace Element Res 1997, 56: 143–152. 10.1007/BF02785388CrossRef
57.
Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky VA, Deth RC: Activation of methionine synthase by insulin-like growth factor and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 2004, 9: 358–370. 10.1038/sj.mp.4001476PubMedCrossRef
58.
Deth RC: Truth revealed: New scientific discoveries regarding mercury in medicine and autism. Congression Testimony before the US House of Representatives. Subcommittee in human rights and wellness 2004.
59.
Palkovicova L, Ursinyova M, Masanova V, Yu Z, Hertz-Picciotto I: Maternal amalgam dental fillings as the source of mercury exposure in developing fetus and newborn. J Expo Sci Environ Epidemiol 2008, 18(Suppl 3):326–331. 10.1038/sj.jes.7500606PubMedCrossRef
60.
Unuvar E, Ahmadov H, Kiziler AR: Mercury levels in cord blood and meconium of healthy newborns and venous blood of their mothers: Clinical, prospective cohort study. Sci Total Environ 2007, 374(Suppl 1):60–70.PubMedCrossRef
61.
Jedrychowski W, Jankowski J, Flak E, Skarupa A, Mroz E, Sochacka-Tatara E, Lisowska-Miszczyk I, Szpanowska-Wohn A, Rauh V, Skolicki Z, Kaim I, Perera F: Effects of prenatal exposure to mercury on cognitive and psychomotor function in one-year-old infants: epidemiologic cohort study in Poland. Ann Epidemiol 2006, 16: 439–447. 10.1016/j.annepidem.2005.06.059PubMedCrossRef
62.
Stoz F, Aicham P, Jovanovic S, Steuer W, Mayer R: Ist ein generelles Amalgam-Verbot gerechtfertigt? [Is a generalized amalgam banning appropriate?]. Z Geburtsh Neonat 1995, 199: 35–41.
63.
Hargreaves RJ, Evans JG, Janota I, Magos L, Cavanagh JB: Persistant mercury in nerve cells 16 years after metallic mercury poisoning. Neuropath Appl Neurobiol 1988, 14: 443–452. 10.1111/j.1365-2990.1988.tb01336.xCrossRef
64.
Opitz H, Schweinsberg F, Grossmann T, Wendt-Gallitelli MF, Meyermann R: Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure. Clin Neuropath 1996, 15: 139–144.
65.
Drasch G, Böse-O'Reilly S, Beinhoff C, Roider G, Maydl S: The Mt. Diwata study on the Philippines 1999 - assessing mercury intoxication of the population by small scale gold mining. Sci Total Environ 2001, 267: 151–168. 10.1016/S0048-9697(00)00806-8PubMedCrossRef
66.
Drasch G, Böse-O`Reilly S, Maydl S, Roider G: Scientific comment on the German human biological monitoring values (HBM values) for mercury. Int J Hyg Environ Health 2002, 205: 509–512. 10.1078/1438-4639-00178PubMedCrossRef
67.
Drasch G, Böse-O'Reilly S, Maydl S, Roider G: Response to the letter of the Human Biomonitoring Commission. Int J Hyg Environ Health 2004, 207: 183–184. 10.1078/1438-4639-00280CrossRef
68.
Stenman S, Grans L: Symptoms and differential diagnosis of patients fearing mercury toxicity from amalgam fillings. Scand J Work Environ Health 1997, 23: 59–63.PubMed
69.
Grandjean P, Weihe P, White R: Milestone development in infants exposed to methylmercury from human milk. Neurotoxicology 1995, 16: 27–33.PubMed
70.
Köhler W, Linde K, Halbach S, Zilker T, Kremers L, Saller R, Melchart D: Prognos in the diagnosos of amalgam hypersensitivity: a diagnostic case-control study. Forsch Komplement Med 2007, 14: 18–24.CrossRef
71.
72.
Viola P, Cassano GB: The effect of chlorine on mercury vapor intoxication. Autoradiographic study. Med Lavoro 1968, 59: 437–44.PubMed
73.
Kishi R, Doi R, Fukuchi Y, Satoh H, Satoh T, Ono A, Moriwaka F, Tashiro K, Takahata N: Subjective symptoms and neurobehavioral performances of ex-mercury miners at an average of 18 years after the cessation of chronic exposure to mercury vapor. Mercury Workers Study Group. Environl Res 1993, 62: 289–302. 10.1006/enrs.1993.1114CrossRef
74.
Mathiesen T, Ellingsen DG, Kjuus H: Neuropsychological effects associated with exposure to mercury vapor among former chloralkali workers. Scand J Work Environ Health 1999, 25: 342–350.PubMedCrossRef
75.
Meyer-Baron M, Schaeper M, Seeber A: A meta-analysis for neurobehavioral results due to occupational mercury exposure. Arch Toxicol 2002, 76: 127–136. 10.1007/s00204-002-0327-9PubMedCrossRef
76.
Piikivi L, Hanninen H, Martelin T, Mantere P: Psychological performance and long-term exposure to mercury vapors. Scand J Work Environ Health 1984, 10: 35–41.PubMedCrossRef
77.
Roels H, Gennart JP, Lauwerys R, Buchet JP, Malchaire J, Bernard A: Surveillance of workers exposed to mercury vapour: validation of a previously proposed biological threshold limit value for mercury concentration in urine. Am J Ind Med 1985, 7: 45–71. 10.1002/ajim.4700070106PubMedCrossRef
78.
Smith PJ, Langolf GD, Goldberg J: Effects of occupational exposure to elemental mercury on short term memory. Br J Ind Med 1983, 40: 413–419.PubMedCentralPubMed
79.
Soleo L, Urbano ML, Petrera V, Ambrosi L: Effects of low exposure to inorganic mercury on psychological performance. Brit J Ind Med 1990, 47: 105–109.
80.
Williamson AM, Teo RK, Sanderson J: Occupational mercury exposure and its consequences for behaviour. Int Arch Occup Environ Health. 1982, 50: 273–286.
81.
Zavariz C, Glina DM: Clinico-neuro-psychological evaluation of workers exposed to metallic mercury in the electric lamp industry. Rev Saud Publica 1992, 26: 356–65. (In Portugese with English abstract)
82.
He F, Zhow X, Lin B, Xiung YP, Chen SY, Zhang SL, Ru JY, Deng MH: Prognosis of Mercury poisoning in mercury refinery workers. Ann Acad Med Singapore 1984, 13: 389–393.PubMed
83.
Kishi R, Doi R, Fukushi Y, Satoh H, Ono A: Residual neurobehavioural effects associated with chronic exposure to mercury vapour. Occup Environ Med 1994, 51: 35–41. 10.1136/oem.51.1.35PubMedCentralPubMedCrossRef
84.
Kobal A, Horvat M, Prezelj M, Briski AS, Krsnik M, Dizdarevic T, Mazej D, Falnoga I, Stibilj V, Arneric N, Kobal D, Osredkar J: The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol 2004, 17: 261–274. 10.1016/S0946-672X(04)80028-2PubMedCrossRef
85.
Letz R, Gerr F, Cragle D, Green R, Watkins J, Fidler A: Residual neurologic deficits 30 years after occupational exposure to elemental mercury. Neurotoxicology 2000, 21: 459–474.PubMed
86.
Sugita M: The biological half-time of heavy metals. The existence of a third, `slowest' component. Int Arch Occup Environ Health 1978, 41: 25–40. 10.1007/BF00377797PubMedCrossRef
87.
Takahata N, Hayashi H, Watanabe S, Anso T: Accumulation of mercury in the brains of two autopsy cases with chronic inorganic mercury poisoning. Folia Psychiatr Neurol Jpn 1970, 24: 59–69.PubMed
88.
Stoiber T, Bonacker D, Bohm K: Disturbed microtubule function and induction of micronuclei by chelate complexes of mercury(II). Mutat Res 2004, 563: 97–106.PubMedCrossRef
89.
Stoiber T, Degen GH, Bolt HM, Unger E: Interaction of mercury(II) with the microtubule cytoskeleton in IMR-32 neuroblastoma cells. Toxicol Lett 2004, 151(Suppl 1):99–104. 10.1016/j.toxlet.2003.11.017PubMedCrossRef
90.
Thier R, Bonacker D, Stoiber T: Interaction of metal salts with cytoskeletal motor protein systems. Toxicol Lett 2003, 140: 75–81. 10.1016/S0378-4274(02)00502-7PubMedCrossRef
91.
Duhr EF, Pendergrass JC, Slevin JT, Haley BE: HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin. Toxicol Appl Pharmacol 1993, 122: 273–280. 10.1006/taap.1993.1196PubMedCrossRef
92.
Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL: Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain. Neurotoxicology 1996, 18: 315–324.
93.
Soares FA, Farina M, Santos FW, Souza D, Rocha JB, Nogueira CW: Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes. Neurochem Res 2003, 28: 1859–1865. 10.1023/A:1026175825871PubMedCrossRef
94.
Aposhian HV, Morgan DL, Queen HL, Maiorino RM, Aposhian MM: Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor. J Toxicol Clin Toxicol 2003, 41: 339–347. 10.1081/CLT-120022000PubMedCrossRef
95.
Nogueira CW, Soares FA, Nascimento PC, Muller D, Rocha JB: 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase. Toxicology 2003, 184: 85–95. 10.1016/S0300-483X(02)00575-9PubMedCrossRef
96.
Ewan KB, Pamphlett R: Increased inorganic mercury in spinal motor neurons follwoing chelating agents. Neurotoxicology 1996, 17: 343–349.PubMed
97.
Harris HH, Pickering IJ, George GN: The chemical form of mercury in fish. Science 2003, 301: 1203. 10.1126/science.1085941PubMedCrossRef
98.
Fredriksson A, Dencker L, Archer T, Danielsson BR: Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats. Neurotoxicol Teratol 1996, 18: 129–134. 10.1016/0892-0362(95)02059-4PubMedCrossRef
99.
Lettmeier B, Böse o, Reilly S, Drasch G: Proposal for a revised reference concentration (RFC) for mercury vapour in adults. Sci Total Environ 2010.
100.
101.
Schubert J, Riley EJ, Tyler SA: Combined effects in toxicology - a rapid systematic testing procedure: cadmium, mercury, and lead. J Toxicol Environ Health 1978, 4: 763–776. 10.1080/15287397809529698PubMedCrossRef
102.
103.
Ericson JE, Shirahata H, Patterson CC: Skeletal concentrations of lead in ancient Peruvians. N Engl J Med 1979, 300: 946–951. 10.1056/NEJM197904263001703PubMedCrossRef
104.
Ericson JE, Smith DR, Flegal AR: Skeletal concentrations of lead, cadmium, zinc, and silver in ancient North American Pecos Indians. Environ Health Perspect 1991, 93: 217–223. 10.2307/3431192PubMedCentralPubMedCrossRef
105.
Drasch G: Lead burden in prehistorical, historical and modern human bones. Sci Total Environ 1982, 24: 199–231. 10.1016/0048-9697(82)90001-8PubMedCrossRef
106.
Patterson CC, Shirahata H, Ericson JE: Lead in ancient human bones and the relevance to historical developments of social problems with lead. Sci Total Environ 1987, 61: 167–200. 10.1016/0048-9697(87)90366-4PubMedCrossRef
107.
Patterson CC, Shirahata H, Ericson JE: Natural skeletal levels of lead in Homo sapiens sapiens uncontaminated by technological lead. Sci Total Environ 1991, 107: 205–236. 10.1016/0048-9697(91)90260-LPubMedCrossRef
108.
Haley B: Mercury toxicity: Genetic susceptibilities and synergistic effects. Medical Veritas 2005, 2: 535–542. 10.1588/medver.2005.02.00070CrossRef
109.
Haley B, Small T: Biomarkers supporting mercury toxicity as the major exacerbator of neurological illness, recent evidence via the urine prophyrin tests. Medical Veritas 2006, 3: 1–14.
110.
Kehe K, Reichl FX, Durner J, Walther U, Hickel R, Forth W: Cytotoxicity of dental composite components and mercury compounds in pulmonary cells. Biomaterials 2001, 22: 317–322. 10.1016/S0142-9612(00)00184-8PubMedCrossRef
111.
Reichl FX, Walther UI, Durner J, Kehe K, Hickel R, Kunzelmann KH, Spahl W, Hume WR, Benschop H, Forth W: Cytotoxicity of dental composite components and mercury compounds in lung cells. Dent Mater 2001, 17: 95–101. 10.1016/S0109-5641(00)00029-4PubMedCrossRef
112.
Reichl FX, Simon S, Esters M, Seiss M, Kehe K, Kleinsasser N, Hickel R: Cytotoxicity of dental composite (co)monomers and the amalgam component Hg(2+) in human gingival fibroblasts. Arch Toxicol 2006, 80: 465–472. 10.1007/s00204-006-0073-5PubMedCrossRef
113.
Reichl FX, Esters M, Simon S, Seiss M, Kehe K, Kleinsasser N, Folwaczny M, Glas J, Hickel R: Cell death effects of resin-based dental material compounds and mercurials in human gingival fibroblast. Arch Toxicol 2006, 80: 370–377. 10.1007/s00204-005-0044-2PubMedCrossRef
114.
Walther UI, Walther SC, Liebl B, Kehe K, Hickel R, Kunzelmann KH, Spahl W, Hume WR, Benschop H, Forth W: Cytotoxicity of ingredients of various dental materials and related compounds in L2- and A549 cells. J Biomed Mater Res 2002, 63: 643–649. 10.1002/jbm.10384PubMedCrossRef
115.
Di Pietro A, Visalli G, La Maestra S: Biomonitoring of DNA damage in peripheral blood lymphocytes of subjects with dental restorative fillings. Mutat Res 2008, 650: 115–122.PubMedCrossRef
116.
Schmid K, Sassen A, Staudenmaier R: Mercury dichloride induces DNA-damage in human salivary gland tissue calls and lymphocytes. Arch Toxicol 2007, 1: 759–767. 10.1007/s00204-007-0208-3CrossRef
117.
Akiyama M, Oshima H, Nakamura M: Genotoxicity of mercury used in chromosome aberration tests. Toxicol in Vitro 2001, 15: 463–467. 10.1016/S0887-2333(01)00051-0PubMedCrossRef
118.
Pizzichini M, Fonzi M, Sugherini L, Fonzi L, Gasparoni A, Comporti M, Pompella A: Release of mercury from dental amalgam and its influence on salivary antioxidant activity. Bull Group Int Rech Sci Stomatol Odontol 2000, 42: 94–100.PubMed
119.
Pizzichini M, Fonzi M, Sugherini L, Fonzi L, Comporti M, Gasparoni A, Pompella A: Release of mercury from dental amalgam and its influence on salivary antioxidant activity. Sci Total Environ 2002, 284: 19–25. 10.1016/S0048-9697(01)00853-1PubMedCrossRef
120.
Pizzichini M, Fonzi M, Gasparoni A, Fonzi L, Comporti M, Gasparoni A, Pompella A: Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors. Bull Group Int Rech Sci Stomatol Odontol 2001, 43: 62–67.PubMed
121.
Pizzichini M, Fonzi M, Giannerini F, Mencarelli M, Gasparoni A, Rocchi G, Kaitsas V, Fonzi L: Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors. Sci Total Environ 2003, 301: 43–50. 10.1016/S0048-9697(02)00291-7PubMedCrossRef
122.
Ionescu JG, Novotny J, Stejskal V, Lätsch A, Blaurock-Busch E, Eisenmann-Klein M: Increased levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett 2006, 27: 36–39.PubMed
123.
Drasch G, Mailänder S, Schlosser C, Roider G: Content of non-mercury-associated selenium in human tissues. Biol Trace Element Res 2000, 77: 219–230. 10.1385/BTER:77:3:219CrossRef
124.
Mutter J, Curth A, Naumann J, Deth R, Walach H: Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism. J Alzheimers Dis 2010, 22: 357–374.PubMed
125.
Liebert CA, Wireman J, Smith T, Summers AO: The impact of mercury released from dental "silver" fillings on antibiotic resistances in the primate oral and intestinal bacterial flora. Met Ions Biol Syst 1997, 34: 441–460.PubMed
126.
Lorscheider FL, Vimy MJ, Summers AO, Zwiers H: The dental amalgam mercury controversy--inorganic mercury and the CNS; genetic linkage of mercury and antibiotic resistances in intestinal bacteria. Toxicology 1995, 97: 19–22. 10.1016/0300-483X(94)02964-VPubMedCrossRef
127.
Summers AO, Wireman J, Vimy MJ, Lorscheider FL, Marshall B, Levy SB: Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother 1993, 37: 825–834.PubMedCentralPubMedCrossRef
128.
Davis IJ, Roberts AP, Ready D, Richards H, Wilson M, Mullany P: Linkage of a novel mercury resistance operon with streptomycin resistance on a conjugative plasmid in Enterococcus faecium. Plasmid 2005, 54: 26–38. 10.1016/j.plasmid.2004.10.004PubMedCrossRef
129.
Skurnik D, Ruimy R, Ready D, Ruppe E, Bernède-Bauduin C, Djossou F, Guillemot D, Pier GB, Andremont A: Is exposure to mercury a driving force for the carriage of antibiotic resistance genes? J Med Microbiol 2010, 59: 804–807. 10.1099/jmm.0.017665-0PubMedCrossRef
130.
Leistevuo J, Jarvinen H, Osterblad M, Leistevuo T, Huovinen P, Tenovuo J: Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother 2000, 44: 456–457. 10.1128/AAC.44.2.456-457.2000PubMedCentralPubMedCrossRef
131.
Pike R, Lucas V, Stapleton P, Gilthorpe MS, Roberts G, Rowbury R, Richards H, Mullany P, Wilson M: Prevalence and antibiotic resistance profile of mercury-resistant oral bacteria from children with and without mercury amalgam fillings. J Antimicrob Chemother 2002, 49: 777–783. 10.1093/jac/dkf019PubMedCrossRef
132.
Wireman J, Liebert CA, Smith T, Summers AO: Association of mercury resistance with antibiotic resistance in the gram-negative fecal bacteria of primates. Appl Environ Microbiol 1997, 63: 4494–4503.PubMedCentralPubMed
133.
Harris HH, Vogt S, Eastgate H, Legnini DG, Hornberger B, Cai Z, Lai B, Lay PA: Migration of mercury from dental amalgam through human teeth. J Synchrotron Radiat 2008, 15: 123–128. 10.1107/S0909049507061468PubMedCrossRef
134.
Weidinger S, Kramer U, Dunemann L, Mohrenschlager M, Ring J, Behrendt H: Body burden of mercury is associated with acute atopic eczema and total IgE in children from southern Germany. J Allergy Clin Immunol 2004, 114: 457–459. 10.1016/j.jaci.2004.04.011PubMedCrossRef
135.
Berlin M: Mercury in dental-filling materials - an updated risk analysis in environmental medical terms. In The Dental Material Comission - Care and Consideration. Sweden; 2003.
136.
Dunsche A, Frank M, Luttges J, Açil Y, Brasch J, Christophers E, Springer IN: Lichenoid reactions of murine mucosa associated with amalgam. Br J Dermatol 2003, 148: 741–748. 10.1046/j.1365-2133.2003.05229.xPubMedCrossRef
137.
Dunsche A, Kastel I, Terheyden H, Springer I, Christophers E, Brasch J: Oral lichenoid reactions associated with amalgam: improvement after amalgam removal. Br J Dermatol 2003, 148: 70–76. 10.1046/j.1365-2133.2003.04936.xPubMedCrossRef
138.
Martin M, Broughton S, Drangsholt M: Oral lichen planus and dental materials: a case-control study. Contact Dermatitis 2003, 48: 331–336. 10.1034/j.1600-0536.2003.00146.xPubMedCrossRef
139.
Wong L, Freeman S: Oral lichenid lesions (OLL) and mercury in amalgam fillings. Contact Dermatitis 2003, 48: 74–79. 10.1034/j.1600-0536.2003.480204.xPubMedCrossRef
140.
Guttman-Yassky E, Weltfriend S, Bergman R: Resolution of orofacial granulomatosis with amalgam removal. J Eur Acad Dermatol Venerol 2003, 17: 344–347. 10.1046/j.1468-3083.2003.00793.xCrossRef
141.
Guarneri F, Marini H: Perioral dermatitis after dental filling in a 12-year-old girl: involvement of cholinergic system in skin neuroinflammation? ScientificWorldJournal 2008, 8: 157–163. 10.1100/tsw.2008.31PubMedCrossRef
142.
Pigatto PD, Brambilla L, Guzzi G: Mercury pink exanthem after dental amalgam placement. J Eur Acad Dermatol Venereol 2008, 22: 377–378. 10.1111/j.1468-3083.2007.02332.xPubMedCrossRef
143.
Bartova J, Prochazkova J, Kratka Z, Benetkova K, Venclikova Z, Sterzl I: Dental amalgam as one of the risk factors in autoimmune diseases. Neuro Endocrinol Lett 2003, 24: 65–67.PubMed
144.
Hultman P, Johansson U, Turley S, Lindh U, Enestrom S, Pollard K: Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice. FASEB Journal 1994, 8: 1183–1190.PubMed
145.
Hultman P, Lindh U, Horsted-Binslev P: Activation of the immune system and systemic immune-complex deposits in Brown Norway rats with dental amalgam restorations. J Dent Res 1998, 77: 1415–1425. 10.1177/00220345980770060601PubMedCrossRef
146.
Pollard KM, Pearson DL, Hultman P, Deane TN, Lindh U, Kono DH: Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxbs mice. Environ Health Persp 2001, 109: 27–33. 10.2307/3434917CrossRef
147.
Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VDM: The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuro Endocrinol Lett 2004, 25: 211–218.PubMed
148.
Stejskal J, Stejskal VD: The role of metals in autoimmunity and the link to neuroendocrinology. Neuro Endocrinol Lett 1999, 20: 351–364.PubMed
149.
Stejskal VD, Danersund A, Lindvall A: Metal-specific lymphocytes: biomarkers of sensitivity in man. Neuro Endocrinol Lett 1999, 20: 289–298.PubMed
150.
Sterzl I, Procházková J, Hrdá P, Bártová J, Matucha P, Stejskal VDM: Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuro Endocrinol Lett 1999, 20: 221–228.PubMed
151.
Via CS, Nguyen P, Niculescu F, Papadimitriou J, Hoover D, Silbergeld EK: Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect 2003, 111: 1273–1277. 10.1289/ehp.6064PubMedCentralPubMedCrossRef
152.
Sterzl I, Procházková J, Hrda P, Matucha P, Bartova J, Stejskal V: Removal of dental amalgam decreases anto-TPO and anti-Tg autoantibodies in patients with autoimmune thyroiditis. Neuro Endocrinol Lett 2006, 5(27(Suppl 1):25–30.
153.
Kazantzis G: Mercury exposure and early effects: an overview. Med Lav 2002, 93: 139–147.PubMed
154.
Rampersad GC, Suck G, Sakac D, Fahim S, Foo A, Denomme GA, Langler RF, Branch DR: Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells. Transfusion 2005, 45: 384–393. 10.1111/j.1537-2995.2005.04241.xPubMedCrossRef
155.
Bartram F, Donate HP, Müller KE, Bückendorf CH, Ohnsorge P, Huber W, von Baehr V: Significance of the patch test and the lymphocyte transformation test in the diagnostic of type IV-sensitazion. J Lab Med 2006, 30: 101–106.
156.
Venclíková Z, Benada O, Bártová J, Joska L, Mrklas L, Procházková J, Stejskal V, Podzimek S: In vivo effects of dental casting alloys. Neuro Endocrinol Lett 2006, 27(Suppl 1):61–68.PubMed
157.
Valentine-Thon E, Schiwara HW: Validity of MELISA for metal sensitivity testing. Neuro Endocrinol Lett 2003, 24: 50–55.
158.
Valentine-Thon E, Sandkamo M, Müller K, Guzzi G, Hartmann T: Metallsensibilisierung: Nachweis, Validierung und Verlaufskontrolle mittels Lymphozyten-Transformations-Test (LTT-Melisa®). Zs f Orthomol Med 2005, 1: 12–15.
159.
Valentine-Thon E, Muller KE, Guzzi G, Kreisel S, Ohnsorge P, Sandkamp M: LTT-MELISA®is clinically relevant for detecting and monitoring metal sensitivity. Neuro Endocrinol Lett 2006, 27(Suppl1):17–24.PubMed
160.
Yaqob A, Danersund A, Stejskal VD, Lindvall A, Hudecek R, Lindh U: Metal-specific lymphocyte reactivity is downregulated after dental metal replacement. Neuro Endocrinol Lett 2006, 27: 189–197.PubMed
161.
Lindh U, Hudecek R, Dandersund A, Eriksson S, Lindvall A: Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health. Neuro Endocrinol Lett 2002, 23: 459–482.PubMed
162.
Stejskal VD: Diagnosis and treatment of metal-induced side effects. Neuro Endocrinol Lett 2006, 27(Suppl 1):7–16.PubMed
163.
Wortberg W: Intrauterine Fruchtschädigung durch Schwermetallbelastung der Mutter. Umwelt Medizin Gesellschaft 2006, 19: 274–280.
164.
Houston MC: The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Health Med 2007, 13: 128–133,.
165.
Frustaci A, Magnavita N, Chimenti C, Cladarulo M, Sabbioni E, Pietra R: Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction. J Am Coll Cardiol 1999, 33: 1578–1583. 10.1016/S0735-1097(99)00062-5PubMedCrossRef
166.
Dodes JE: The amalgam controversy. An evidence-based analysis. J Am Dent Assoc 2001, 132: 348–356.PubMedCrossRef
167.
Boyd ND, Benediktsson H, Vimy MJ, Hooper DE, Lorscheider FL: Mercury from dental "silver" tooth fillings impairs sheep kidney function. Am J Physiol 1991, 261: 1010–1014.
168.
Trachtenberg F, Barregård L: The effect of age, sex, and race on urinary markers of kidney damage in children. Am J Kidney Dis 2007, 50: 938–945. 10.1053/j.ajkd.2007.08.014PubMedCrossRef
169.
Mutter J, Naumann J, Sadaghiani C, Walach H: Quecksilber und die Alzheimer-Erkrankung. Fortschr Neuro Psychiat 2007, 75: 528–538. 10.1055/s-2007-959237CrossRef
170.
Mutter J, Naumann J, Guethlin C: Comments on the article "the toxicology of mercury and its chemical compounds" by Clarkson and Magos (2006). Crit Rev Toxicol 2007, 37: 537–549. 10.1080/10408440701385770PubMedCrossRef
171.
Carpenter DO: Effects of metals on the nervous system of humans and animals. Int J Occup Med Environ Health 2001, 14: 209–218.PubMed
172.
Dantzig PI: Parkinson's disease, macular degeneration and cutaneous signs of mercury toxicity. J Occup Environ Med 2006, 48: 656.PubMedCrossRef
173.
Finkelstein Y, Vardi J, Kesten MM, Hod I: The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine. Neurotoxicology 1996, 17: 291–295.PubMed
174.
Gorell JM, Rybicki BA, Johnson C, Peterson EL: Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 1999, 18: 303–308. 10.1159/000026225PubMedCrossRef
175.
Miller K, Ochudto S, Opala G, Smolicha W, Siuda J: Parkinsonism in chronic occupational metallic mercury intoxication. Neurol Neurochir Pol 2003, 37: 31–38.PubMed
176.
Ngim CH, Devathasan G: Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. Neuroepidemiology 1989, 8: 128–141. 10.1159/000110175PubMedCrossRef
177.
Ohlson CG, Hogstedt C: Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury - a case-referent study. Scand J Work Environ Health 1981, 7: 252–256.PubMedCrossRef
178.
Rybicki BA, Johnson CC, Uman J, Gorell JM: Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Mov Disord 1993, 8: 87–92. 10.1002/mds.870080116PubMedCrossRef
179.
Seidler A, Hellenbrand W, Robra BP: Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996, 46: 1275–84.PubMedCrossRef
180.
Uversky VN, Li J, Fink AL: Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 2001, 276: 44284–44296. 10.1074/jbc.M105343200PubMedCrossRef
181.
Harakeh S, Sabra N, Kassak K, Doughan B, Sukhn C: Mercury and arsenic levels among Lebanese dentists: a call for action. Bull Environ Contam Toxicol 2003, 70: 629–635. 10.1007/s00128-003-0031-3PubMedCrossRef
182.
Tezel H, Ertas OS, Ozata F, Erakin C, Kayali A: Blood mercury levels of dental students and dentists at a dental school. Br Dent J 2001, 191: 449–452. 10.1038/sj.bdj.4801205aPubMed
183.
Aydin N, Karaoglanoglu S, Yigit A, Keles MS, Kirpinar I, Seven N: Neuropsychological effects of low mercury exposure in dental staff in Erzurum, Turkey. Int Dent J 2003, 53: 85–91.PubMedCrossRef
184.
Bittner ACJ, Echeverria D, Woods JS: Behavioral effects of low-level exposure to HgO among dental professional: a cross-study evaluation of psychomotor effects. Neuortoxicol Teratol 1998, 17: 161–168.
185.
Echeverria D, Heyer NJ, Martin MD, Naleway C, Woods JS, Bittner ACJ: Behavioral effects of low-level exposure to elemental Hg among dentists. Neurotoxicol Teratol 1995, 17: 161–168. 10.1016/0892-0362(94)00049-JPubMedCrossRef
186.
Echeverria D, Woods JS, Heyer N, Rohlman DS, Farin FM, Bittner AC Jr, Li T, Garabedian C: Chronic low-level mercury exposure, BDNF polymorphism and associations with cognitive and motor function. Neurotoxicol Teratol 2005, 27: 781–796. 10.1016/j.ntt.2005.08.001PubMedCrossRef
187.
Heyer NJ, Echeverria D, Bittner AJ, Farin FM, Garabedian CC, Woods JS: Chronic low-level mercury exposure, BDNF polymorphism, and associations with self-reported symptoms and mood. Toxicol Sci 2004, 81: 354–363. 10.1093/toxsci/kfh220PubMedCrossRef
188.
Heyer NJ, Bittner AJ, Echerverria D, Woods J: A cascade analysis of the interaction of mercury and coproporphyrinogen-oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production. Toxicol Lett 2006, 161: 159–166. 10.1016/j.toxlet.2005.09.005PubMedCrossRef
189.
Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M: Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. J Pharmacol Exp Ther 1995, 272: 264–274.PubMed
190.
Langworth S, Sallsten G, Barregard L, Cynkier I, Lind ML, Soderman E: Exposure to mercury vapor and impact on health in the dental profession in Sweden. J Dent Res 1997, 76: 1397–1404. 10.1177/00220345970760071001PubMedCrossRef
191.
Moen BE, Hollund BE, Riise T: Neurological symptoms among dental assistants: a cross-sectional study. J Occup Med Toxicol 2008, 18: 3–10.
192.
Ngim CH, Foo SC, Boey KW, Jeyaratnam J: Chronic neurobehavioral effects of elemental mercury in dentists. Br J Ind Med 1992, M49: 782–790.
193.
Ritchie KA, Macdonald EB, Hammersley R, O'Neil JM, McGowan DA, Dale IM, Wesnes K: A pilot study of the effect of low level exposure to mercury on the health of dental surgeons. J Occup Environ Med 1995, 52: 813–817. 10.1136/oem.52.12.813CrossRef
194.
Ritchie KA, Gilmour WH, Macdonald EB, Burke FJ, McGowan DA, Dale IM, Hammersley R, Hamilton RM, Binnie V, Collington D: Health and neuropsychological functioning of dentists exposed to mercury. J Occup Environ Med 2002, 59: 287–293. 10.1136/oem.59.5.287CrossRef
195.
Uzzell BP, Oler J: Chronic low-level mercury exposure and neuropsychological functioning. J Clin Exp Neuropsychol 1986, 8: 581–593. 10.1080/01688638608405177PubMedCrossRef
196.
Urban P, Lukas E, Nerudova J, Cabelkova Z, Cikrt M: Neurological and electrophysiological examinations on three groups of workers with different levels of exposure to mercury vapors. Eur J Neurol 1999, 6: 571–577. 10.1046/j.1468-1331.1999.650571.xPubMedCrossRef
197.
Nadorfy-Lopez E, Torres SH, Finol H, Mendez M, Bello B: Skeletal muscle abnormalities associated with occupational exposure to mercury vapors. Hist Histopath 2000, 15: 673–682.
198.
Rowland A, Baird D, Weinberg C, Shore D, Shy C, Wilcox A: The effect of occupational exposure to the mercury vapour on the fertility of female dental assistants. Occup Environ Med 1994, 51: 28–34. 10.1136/oem.51.1.28PubMedCentralPubMedCrossRef
199.
Lindbohm ML, Ylöstalo P, Sallmen M: Occupational exposure in dentistry and miscarriage. Occup Environ Med 2007, 64: 127–133. 10.1136/oem.2005.026039PubMedCentralPubMedCrossRef
200.
Jones L, Bunnell J, Stillman J: A 30-year follow-up of residual effects on New Zealand School Dental Nurses, from occupational mercury exposure. Hum Exp Toxicol 2007, 26: 367–374. 10.1177/0960327107076824PubMedCrossRef
201.
Echeverria D, Woods JS, Heyer NJ, Rohlman D, Farin FM, Li T, Garabedian CE: The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol Teratol 2006, 28: 39–48. 10.1016/j.ntt.2005.10.006PubMedCrossRef
202.
Gerhard I, Monga B, Waldbrenner A, Runnebaum B: Heavy metals and fertility. J Toxicol Environ Health. 1998, 54: 593–611.
203.
Gerhard I, Waibel S, Daniel V, Runnebaum B: Impact of heavy metals on hormonal and immunological factors in women with repeated miscarriages. Hum Reprod Update 1998, 4: 301–309. 10.1093/humupd/4.3.301PubMedCrossRef
204.
Gerhard I, Runnebaum B: The limits of hormone substitution in pollutant exposure and fertility disorders. Zentralbl Gynaekol 1992, 114: 593–602.
205.
Sheiner EK, Sheiner E, Hammel RD, Potashnik G, Carel R: Effect of occupational exposures on male fertility: literature review. Ind Health 2003, 41:5: 5–62.
206.
Podzimek S, Prochazkova J, Pribylova L, Bártová J, Ulcová-Gallová Z, Mrklas L, Stejskal VD: Effect of heavy metals on immune reactions in patients with infertility. Cas Lek Cesk 2003, 142: 285–288.PubMed
207.
Podzimek S, Prochazkova J, Bultasova L, Bartova J, Ulcova-Gallova Z, Mrklas L, Stejskal VD: Sensitization to inorganic mercury could be a risk factor for infertility. Neuro Endocrinol Lett 2005, 26: 277–282.PubMed
208.
Ahlrot-Westerlund B: Mercury in cerebrospinal fluid in multiple sclerosis. Swed J Biol Med 1989, 1: 6–7.
209.
Craelius W: Comperative epidemiology of multiple sclerosis and dental caries. J Epidemiol Comm Health 1978, 32: 155–165. 10.1136/jech.32.3.155CrossRef
210.
McGrother C, Dugmore C, Phillips M, Raymond N, Garrick P, Baird W: Multiple sclerosis, dental caries and fillings: a case-control study. Br Dent J 1999, 187: 261–264. 10.1038/sj.bdj.4800255aPubMed
211.
Baasch E: Theoretical considerations on the etiology of multiple sclerosis. Is multiple sclerosis a mercury allergy? Schweiz Arch Neurol Neurochir Psychiatr 1966, 98: 1–19.PubMed
212.
Ingalls T: Epidemiology, etiology and prevention of multiple sclerosis. Hypothesis and fact. Am J Forensic Med Pathol 1983, 4: 55–61. 10.1097/00000433-198303000-00006PubMedCrossRef
213.
Ingalls T: Endemic clustering of multiple sclerosis in time and place, 1934–1984. Confirmation of a hypothesis. Am J Forensic Med Pathol 1986, 7: 3–8. 10.1097/00000433-198603000-00002PubMedCrossRef
214.
Issa Y, Watts D, Duxbury A, Brunton P, Watson M, Waters C: Mercuric chloride: toxicity and apoptosis in a human oligodendroglial cell line. Biomaterials 2003, 24: 981–987. 10.1016/S0142-9612(02)00436-2PubMedCrossRef
215.
Siblerud RL: A comparison of mental health of multiple sclerosis patients with silver/mercury dental fillings and those with fillings removed. Psychol Rep 1992, 70: 1139–1151. 10.2466/PR0.70.4.1139-1151PubMedCrossRef
216.
Siblerud RL, Kienholz E, Motl J: Evidence that mercury from silver dental fillings may be an etiological factor in smoking. Toxicol Lett 1993, 68: 307–310. 10.1016/0378-4274(93)90022-PPubMedCrossRef
217.
Huggins HA, Levy TE: Cerebrospinal fluid protein changes in multiple sclerosis after dental amalgam removal. Altern Med Rev 1998, 4: 295–300.
218.
Bates M, Fawcett J, Garrett N, Cutress T, Kjellstrom T: Related articles, health effects of dental amalgam exposure: a retrospective cohort study. Int J Epidemiol 2004, 33: 894–902. 10.1093/ije/dyh164PubMedCrossRef
219.
Bates MN: Mercury amalgam dental fillings: an epidemiologic assessment. Int J Hyg Environ Health 2006, 209(Suppl 4):309–316. 10.1016/j.ijheh.2005.11.006PubMedCrossRef
220.
Aminzadeh KK, Etminan M: Dental amalgam and multiple sclerosis: a systematic review and meta-analysis. J Public Health Dent 2007, 67: 64–66. 10.1111/j.1752-7325.2007.00011.xPubMedCrossRef
221.
Pamphlett R, Coote P: Entry of low doses of mercury vapor into the nervous system. Neurotoxicology 1998, 19: 39–47.PubMed
222.
Pamphlett R, Slater M, Thomas S: Oxidative damage to nuclic acids in motor neurons containing mercury. J Neurol Sci 1998, 159: 121–126. 10.1016/S0022-510X(98)00161-0PubMedCrossRef
223.
Pamphlett R, Waley P: Motor neuron uptake of low dose inorganic mercury. J Neurol Sci 1996, 135: 63–67. 10.1016/0022-510X(95)00258-4PubMedCrossRef
224.
Praline J, Guennoc AM, Limousin N, Hallak H, deToffol B, Corcia P: ALS and mercury intoxication: a relationship? Clin Neurol Neurosurg 2007, 109(Suppl 10):880–883. 10.1016/j.clineuro.2007.07.008PubMedCrossRef
225.
Stankovic R: Atrophy of large myelinated motor axons and declining muscle grip strength following mercury vapour inhalation in mice. Inhal Toxicol 2006, 18: 57–69. 10.1080/08958370500282902PubMedCrossRef
226.
Albrecht J, Matya E: Glutamate: a potential mediator of inorganic mercury neurotoxicity. Metab Brain Dis 1996, 11: 175–184. 10.1007/BF02069504PubMedCrossRef
227.
Adams C, Ziegler D, Lin J: Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA 1983, 250: 642–643. 10.1001/jama.250.5.642PubMedCrossRef
228.
Schwarz S, Husstedt I, Bertram H, Kuchelmeister K: Amyotrophic lateral sclerosis after accidental injection of mercury. J Neurol Neurosurg Psychiatry 1996, 60: 698. 10.1136/jnnp.60.6.698PubMedCentralPubMedCrossRef
229.
Redhe O, Pleva J: Recovery from amyotrophic lateral sclerosis and from allergy after removal of dental amalgam fillings. Int J Risk Saf Med 1994, 4: 229–236.PubMed
230.
Engel P: Beobachtungen über die Gesundheit vor und nach Amalgamentfernung. [Observations on health before and after removing dental amalgam]. Schweiz Monatsschr Zahnm 1998, 108: 2–14.
231.
Godfrey ME, Wojcik DP, Krone CA: Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. J Alz Dis 2003, 5: 189–195.
232.
Siblerud RL: The relationship between mercury from dental amalgam and mental health. Am J Psychother 1989, 43: 575–587.PubMed
233.
Siblerud RL, Motl J, Kienholz E: Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety. Psychol Rep 1994, 74: 67–80.PubMedCrossRef
234.
Wojcik DP, Godfrey ME, Haley B: Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994–2006). Neuro Endocrinol Lett 2006, 27: 415–423.PubMed
235.
Marcusson J: Psychological and somatic subjective as a result of dermatological patch testing with metallic mercury and phenyl mercuric acetate. Toxicol Lett 1996, 84: 113–122. 10.1016/0378-4274(95)03623-7PubMedCrossRef
236.
Marcusson J, Jarstrand C: Oxidative metabolism of neutrophils in vitro and human mercury intolerance. Toxicol in Vitro 1998, 12: 383–388. 10.1016/S0887-2333(98)00018-6PubMedCrossRef
237.
Marcusson J: The frequency of mercury intolerance in patients with chronic fatigue syndrome and healthy controls. Contact Dermatitis 1999, 41: 60–61. 10.1111/j.1600-0536.1999.tb06225.xPubMedCrossRef
238.
Woods J Martin, Naleway CA, Echeverria D: Urinary porphyrin profiles as a biomarker of mercury exposure: studies on dentists with occupational exposure to mercury vapor. J Toxicol Environ Health 1993, 40: 235–46. 10.1080/15287399309531791PubMedCrossRef
239.
Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R: Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol 2006, 214: 99–108. 10.1016/j.taap.2006.04.008PubMedCrossRef
240.
Geier DA, Geier MR: A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox Res 2006, 10: 57–64. 10.1007/BF03033334PubMedCrossRef
241.
Geier DA, Geier MR: A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett 2006, 27: 401–413.PubMed
242.
Woods JS, Echeverria D, Heyer NJ, Simmonds PL, Wilkerson J, Farin FM: The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Toxicol Appl Pharmacol 2005, 206: 113–120. 10.1016/j.taap.2004.12.016PubMedCrossRef
243.
Atamna H, Frey WH: A Role for heme in Alzheimer's disease: Heme binds amyolid β and has altered metabolism. PNAS 2004, 101(Suppl 30):153–158.
244.
Stewart WF, Schwartz BS, Simon D, Kelsey K, Todd AC: ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ Health Perspect 2002, 110: 501–505. 10.1289/ehp.02110501PubMedCentralPubMedCrossRef
245.
Mutter J, Naumann J, Schneider R, Walach H, Haley B: Mercury an autism: Accelerating evidence? Neuro Endocrinol Lett 2005, 26: 431–437.
246.
Mutter J, Naumann J, Walach H, Daschner F: Amalgam: Eine Risikobewertung unter Berücksichtigung der neuen Literatur bis 2005. Gesundheitswesen 2005, 67: 204–216. 10.1055/s-2005-857962PubMedCrossRef
247.
Mutter J, Naumann J, Sadaghiani C, Walach H, Drasch G: Mercury an autism: Response to the letter of K.E.v. Muehlendahl. Int J Hyg Environ Health 2005, 208: 437–438. 10.1016/j.ijheh.2005.06.001CrossRef
248.
Kidd R: Results of dental amalgam removal and mercury detoxification using DMPS and neural therapy. Altern Ther Health 2000, 6: 49–55.
249.
Lindforss H, Marqvardsen O, Olsson S, Henningson M: Effekter på hälsan efter avlägsnandet av amalgamfyllingar. Enodontologisk, medicinsk och psykosomatisk studie. Tandläkartidningen 1994, 86: 205–211.
250.
Lygre GB, Gjerdet NR, Bjorkman L: Patients' choice of dental treatment following examination at a specialty unit for adverse reactions to dental materials. Acta Odontol Scand 2004, 62: 258–263. 10.1080/00016350410001694PubMedCrossRef
251.
Stomberg R, Langworth S: Mercury in dental-filling materials - an updated risk analysis in environmental medical terms. The dental Material Commission - Care and Consideration. In Edited by: Berlin M. Sweden. 2003, 19.
252.
Faustman EM, Silbernagel SM, Fenske RA, Burbacher T, Ponce RA: Mechanisms underlying children's susceptibility to environmental toxicants. Environ Health Perspect 2000, 108: 13–21. 10.2307/3454629PubMedCentralPubMedCrossRef
253.
Cheuk DK, Wong V: Attention-deficit hyperactivity disorder and blood mercury level: a case control study in Chinese children. Neuropediatrics 2006, 37: 234–240. 10.1055/s-2006-924577PubMedCrossRef
254.
Desoto MC, Hitlan RT: Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J Child Neurol 2007, 22: 1308–1311. 10.1177/0883073807307111PubMedCrossRef
255.
Adams JB, Romdalvik J, Ramanujam VM, Legator MS: Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health 2007, 70: 1046–1051. 10.1080/15287390601172080CrossRef
256.
Evans TA, Siedlak SL, Lu L: The autistic phenotype exhibits remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am J Biochem Biotechnol 2008, 4: 61–72. 10.3844/ajbbsp.2008.61.72CrossRef
257.
Lopez-Hurtado E, Prieto JJ: A microscopic study of language-related cortex in autism. Am J Biochem Biotechnol 2008, 4: 130–145. 10.3844/ajbbsp.2008.130.145CrossRef
258.
Sajdel-Sulkowska EM, Lipinski B, Windom H, Audhya T, McGinnis W: Oxidative stress in autism: elevated cerebellar 3-nitrotyrosine levels. Am J Biochem Biotechnol 2008, 4: 73–84. 10.3844/ajbbsp.2008.73.84CrossRef
259.
Bradstreet J, Geier D, Kartzinel J, Adams J, Geier M: A case-control study of mercury burden in children with autistic spectrum disorders. J Am Phys Surg 2003, 8: 76–79.
260.
Geier DA, Geier MR: A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. J Toxicol Environ Health 2007, 70: 837–851. 10.1080/15287390701212141CrossRef
261.
Geier DA, Geier MR: A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health. 2007, 70: 1723–1730.
262.
Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J: Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin Pharmacol 2009, 9: 17. 10.1186/1472-6904-9-17PubMedCentralPubMedCrossRef
263.
Geier DA, Kern JK, Geier MR: A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity. Acta Neurobiol Exp 2009, 69: 189–197.
264.
Geier DA, Mumper E, Gladfelter B, Coleman L, Geier MR: Neurodevelopmental Disorders, Maternal Rh-Negativity, and Rho(D) Immune Globulins: A Multi-Center Assessment. Neuro Endocrinol Lett 2008, 29: 272–280.PubMed
265.
Hornig M, Chian D, Lipkin W: Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 2004, 9: 833–845. 10.1038/sj.mp.4001529PubMedCrossRef
266.
Amin-Zaki L, Majeed MA, Greenwood MR, Elhassani SB, Clarkson TW, Doherty RA: Methylmercury poisoning in the Iraqi suckling infant: a longitudinal study over five years. J Appl Toxicol 1981, 1: 210–214. 10.1002/jat.2550010405PubMedCrossRef
267.
Counter SA, Buchanan LH, Ortega F, Laurell G: Elevated blood mercury and neuro-otological observations in children of the Ecuadorian gold mines. J Toxicol Environ Health 2002, 65: 149–163. 10.1080/152873902753396785CrossRef
268.
Debes F, Budtz-Jorgensen E, Weihe P, White RF, Grandjean P: Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol 2006, 28: 363–75. 10.1016/j.ntt.2006.02.004PubMedCentralPubMedCrossRef
269.
Palmer R, Blanchard S, Stein Z, Mandell D, Miller C: Environmental mercury release, special education rates and autism disorder: an ecological study of Texas. Health&Place 2006, 12: 203–209.
270.
Rury J: Links between environmental mercury special education and autism in Louisiana. PhD thesis. Louisiana State University, Baton Rouge (LA); 2006.
271.
Windham GC, Zhang L, Gunier R, Croen LA, Grether JK: Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect 2006, 114: 1438–1444. 10.1289/ehp.9120PubMedCentralPubMedCrossRef
272.
James S, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA: Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004, 80: 1611–1617.PubMed
273.
James SJ, Slikker W, Melnyk S, New E, Pogribna M, Jernigan S: Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology 2005, 26: 1–8. 10.1016/j.neuro.2004.07.012PubMedCrossRef
274.
275.
Zahir F, Rizwi SJ, Haq SK, Khan RH: Low dose mercury toxicity and human health. Environ Toxicol Pharmacol 2005, 20: 351–360. 10.1016/j.etap.2005.03.007PubMedCrossRef
276.
Bjorkman L, Pedersen NL, Lichtenstein P: Physical and mental health related to dental amalgam fillings in Swedish twins. Community Dent Oral Epidemiol 1996, 24: 260–267. 10.1111/j.1600-0528.1996.tb00856.xPubMedCrossRef
277.
Bellinger DC, Needleman HL: Intellectual impairment and blood lead levels. N Eng J Med 2003, 349: 500–502. 10.1056/NEJM200307313490515CrossRef
278.
DeRouen TA, Martin MD, Leroux BG: Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA 2006, 295(Suppl 15):1784–1792. 10.1001/jama.295.15.1784PubMedCrossRef
279.
Buyske S, Williams TA, Mars AE, Stenroos ES, Ming SX, Wang R, Sreenath M, Factura MF, Reddy C, Lambert GH, Johnson WG: Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism. BMC Genet 2006, 7: 8. 10.1186/1471-2156-7-8PubMedCentralPubMedCrossRef
280.
Chew CL, Soh G, Lee AS, Yeoh TS: Long-term dissolution of mercury from a non-mercury-releasing amalgam. Clin Prev Dent 1991, 13(Suppl 3):5–7.PubMed
281.
282.
Laks DR: Assessment of chronic mercury exposure within the U.S. population, National Health and Nutrition Examination Survey, 1999–2006. Biometals 2009. [Epub ahead of print]
283.
Hylander L, Goodsite M: Environmental costs of the mercury pollution. Sci Total Environ 2006, 368: 352–370. 10.1016/j.scitotenv.2005.11.029PubMedCrossRef
284.
Hylander L, Lindvall A, Gahnberg L: High mercury emissions from dental clinics despite amalgam separators. Sci Total Environ 2006, 362: 74–84. 10.1016/j.scitotenv.2005.06.008PubMedCrossRef
285.
Hylander L, Lindvall A, Uhrberg R, Gahnberg L, Lindh U: Mercury recovery in situ of four different dental amalgam separators. Sci Total Environ 2006, 366: 320–336. 10.1016/j.scitotenv.2005.07.007PubMedCrossRef
286.
287.
288.
289.
290.
291.
Gruning T, Gilmore AB, McKee M: Tobacco Industry Influence on Science and Scientists in Germany. Am J Public Health 2006, 96: 20–32. 10.2105/AJPH.2004.061507PubMedCentralPubMedCrossRef
292.
Hardell L, Walker MJ, Walhjalt B, Friedman LS, Richter ED: Secret ties to industry and conflicting interests in cancer research. Am J Ind Med 2007, 50: 227–233. 10.1002/ajim.20357PubMedCrossRef
293.
Bohm SR, Dian Z, Gilman DS: Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation. Int J Occup Environ Health 2005, 11: 338–348.CrossRef
294.
Jacobson MF: Lifting the veil of secrecy from industry funding of nonprofit health organizations. Int J Occup Environ Health 2005, 11: 349–55.PubMedCrossRef
295.
Egilman DS, Bohme SR: Over a barrel: corporate corruption of science and its effects on workers and the environment. Int J Occup Environ Health 2005, 11: 331–337.PubMedCrossRef
Metadata
Title
Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission
Author
Joachim Mutter
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Occupational Medicine and Toxicology / Issue 1/2011
Electronic ISSN: 1745-6673
DOI
https://doi.org/10.1186/1745-6673-6-2

Other articles of this Issue 1/2011

Journal of Occupational Medicine and Toxicology 1/2011 Go to the issue

Case report

Musculoskeletal disorders early diagnosis: A retrospective study in the occupational medicine setting

Methodology

Methods to recognize work-related cancer in workplaces, the general population, and by experts in the clinic, a Norwegian experience

Research

Defined plant extracts can protect human cells against combined xenobiotic effects

Research

Accuracy of peak VO2 assessments in career firefighters

Research

Biomarkers of oxidative stress and its association with the urinary reducing capacity in bus maintenance workers

Research

The agreement between workers and within workers in regard to occupational exposure to mercury in dental practice assessed from a questionnaire and an interview